Karyopharm Reports Fourth Quarter and Full Year 2014 Financial Results and Highlights Recent Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. EROC
4. SEER
5. FRBT
6. MSTR
7. SNDK
8. NVDA
9. SPGI
10. SEI

Go back to Karyopharm Reports Fourth Quarter and Full Year 2014 Financial Results and Highlights Recent Progress

Karyopharm Therapeutics (KPTI) Misses Q4 EPS by 14c

March 16, 2015 7:16 AM EDT

Karyopharm Therapeutics (NASDAQ: KPTI) reported Q4 EPS of ($0.79), $0.14 worse than the analyst estimate of ($0.65).

Guidance:

Based on current operating plans, Karyopharm expects that its existing cash and cash equivalents will fund its research and development programs and operations into 2018, including moving... More